| Revenue growth | Q2 +14.85%; H1 +12.47% (slide 24/27; slide 5 differs) |
|---|---|
| Margins | H1 PBT down 4.4%; input costs and other expenses rising sharply. |
| Demand visibility | Outlets coverage +19%; lines sold +19%; productive calls +9%. |
Growth
Q2 PBT +20.3% to ₹23.1 Cr. H1 sales +12.5% to ₹238.2 Cr; H1 PBT −4.4%. Women's hygiene +21% in Q2.
Outlook
No explicit revenue/profit guidance given. Ad spend up to ₹12.8 Cr H1 (₹10.6 Cr LY); Cool/Hero Balm launches, DMS rollout.
Risks
Raw/packing material and menthol costs up. Other expenses +32% in H1. ~₹2 Cr exceptional item hit H1 PBT.
Investor Presentation filed with NSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹512.40
- Market cap
- ₹1,481 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 25.9×Sector 41.3×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 3.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Dividend
Amrutanjan Health Care set November 7, 2026 as the record date for its first FY2026-27 interim dividend. The dividend amount per share is not stated.
Amrutanjan Health Care Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 23.6% YoY
Amrutanjan Health Care Ltd reported revenue from operations of ₹135.2 Cr (+14.9% YoY) and net profit of ₹17.3 Cr (+23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +23.6% YoY
Amrutanjan Health Care Board Meeting Date
Amrutanjan Health Care scheduled its board meeting for 3 Nov 2026 to consider Q2/H1 results and 1st interim dividend. No financial figures or dividend amount are stated in this advance intimation.
Amrutanjan Health Care Other Announcement
Amrutanjan Health Care received a voluntary CRISIL ESG rating of 'Adequate' (score 60). No capital or operational impact arises from this rating.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.